Ubiquitome to Participate at BIO International Convention 2019

AUCKLAND, New Zealand, May 31, 2019 /PRNewswire/ — New Zealand-based developer Ubiquitome will be exhibiting at the 2019 BIO International Convention in Philadelphia from 3 – 6 June. This event attracts 16,000+ attendees from over 7,000 businesses worldwide, including the leading biotech and pharma companies.

The Convention celebrates globally important innovations in biotech that start with ‘one’: one meeting, one theory, one trial, one breakthrough.

Ubiquitome will be showcasing its breakthrough ‘Personal’ Genomics Device, the Liberty16. Building on the mobile design philosophy of the company’s ground-breaking Freedom4, the Liberty16 brings unprecedented affordability and flexibility to genomic testing.

The Liberty16 comes with built-in lithium ion batteries for two to three hours of mobile running time, as well as Bluetooth paired with an iPhone app, meaning samples can be run and tested in the field.

An open platform with gold standard performance, the Liberty16 is compatible with industry standard consumables and chemistries such as Taqman® and SYBR.

Where: Pennsylvania Convention Center, Philadelphia, PA
When: 3 – 6 June, 2019
Ubiquitome: Booth #4014

For more information on the BIO International Convention, please visit: http://convention.bio.org/.

ABOUT UBIQUITOME
Ubiquitome is a New Zealand-based developer of handheld, cloud-connected, real-time PCR devices. Ubiquitome’s mission is to enable universal access to genomic information through ubiquitous cloud connected, genetic analysis devices. Visit www.ubiquitomebio.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ubiquitome-to-participate-at-bio-international-convention-2019-300859680.html

SOURCE Ubiquitome

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

2 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

20 hours ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

23 hours ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

23 hours ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

1 day ago